Melqart Asset Management (Uk) LTD Puma Biotechnology, Inc. Transaction History

Melqart Asset Management (Uk) LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$6.5 - $10.73 $3.44 Million - $5.68 Million	-529,112 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$8.75 - $12.85 $4.63 Million - $6.8 Million	529,112 New	529,112 $5.7 Million
Q1 2019 May 15, 2019	SELL	$20.77 - $42.37 $24.1 Million - $49.1 Million	-1,159,790 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$20.07 - $46.7 $15.2 Million - $35.3 Million	756,490 Added 187.58%	1,159,790 $23.6 Million
Q3 2018 Nov 14, 2018	BUY	$41.2 - $59.85 $4.7 Million - $6.83 Million	114,100 Added 39.45%	403,300 $18.5 Million
Q2 2018 Aug 14, 2018	BUY	$48.3 - $68.25 $14 Million - $19.7 Million	289,200 New	289,200 $17.1 Million

102

29.1M

60.6K

16.3K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $132M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Melqart Asset Management (Uk) LTD, based on Form 13F filings with the SEC.

Stay updated on Melqart Asset Management (Uk) LTD with notifications on news.